A consented IBD dataset of 9,800 participants, with a further 30,000 ethically-permissioned records for research related to COVID-19 and IBD. Includes patient demographics, medications plus vaccinations, responses and care received April 2020-June 2021.
inflammatory bowel disease ibd covid-19 sars-cov-2 immune-mediated inflammatory diseases biological therapies immuno-suppressant immune-modifying drugs vulnerable patient groups vaccine